| abstract |
A low side effect composition for treating depressed patients is provided. A pharmaceutical composition comprising mirtazapine, a selective serotonin reuptake inhibitor (SSRI), and a pharmaceutically acceptable adjuvant. In particular, the SSRI is selected from fluoxetine, fluvoxamine, citalopram, celiclamine, femoxetine, sertraline, paroxetine, ifoxetine, cyanodotiepin and ritoxetine. This composition, which can be used to treat depressed patients, has lower side effects than treating patients with mirtazapine or SSRI alone. [Selection figure] None |